BENITEC BIOPHARMA INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c676621f-79e1-4d49-aefd-7854c9007d04/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $0 | 2023-07-01 – 2024-06-30 | evidence 0001193125-24-226968 |
| FY 2023 | $75.0k | 2022-07-01 – 2023-06-30 | evidence 0001193125-23-239121 |
| FY 2022 | $73.0k | 2021-07-01 – 2022-06-30 | evidence 0001193125-22-237075 |
| FY 2021 | $59.0k | 2020-07-01 – 2021-06-30 | evidence 0001193125-21-276758 |
| FY 2020 | $97.0k | 2019-07-01 – 2020-06-30 | evidence 0001193125-20-252381 |
| FY 2019 | $11.6M | 2018-07-01 – 2019-06-30 | evidence 0001193125-20-252381 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BENITEC BIOPHARMA INC. — all facts · Net Income · Operating Income